Full name
"DICOFARM POLSKA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
10.89.Z - Production of other food products, not elsewhere classified
20.42.Z - Manufacture of cosmetics and toilet preparations
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
70.21.Z - Head office activities and management consultancy
73.11.Z - Advertising agency activities
82.30.Z - Activities related to organizing fairs, exhibitions, and congresses
85.60.Z - Educational support activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 2,8 | 3,8 | 6,4 | 67,1 |
EBITDA | 2,8 | 4 | 6,2 | 52,9 |
Short time liabilities | 7,3 | 4,6 | 6,3 | 38,1 |
Equity capital | 1,2 | 4,9 | 10,2 | 109,7 |
Operating profit (EBIT) | 2,8 | 4 | 6,1 | 52,9 |
Assets | 9 | 10,2 | 17,3 | 70,2 |
Net profit (loss) | 2,8 | 3,7 | 5,3 | 46,5 |
Cash | 1,8 | 2,2 | 5,9 | 164,9 |
Liabilities and provisions for liabilities | 7,8 | 5,3 | 7,1 | 33,8 |
Net income from sale | 16,5 | 23,1 | 28,1 | 21,7 |
Working assets | 8,9 | 10 | 17,2 | 71,2 |
Depreciation | 0 | 0 | 0 | 46,8 |
% | % | % | p.p. | |
Profitability of capital | 225,4 | 74,9 | 52,3 | -22,6 |
Equity capital to total assets | 13,6 | 47,9 | 59 | 11,1 |
Gross profit margin | 16,7 | 16,5 | 22,7 | 6,2 |
EBITDA Margin | 16,7 | 17,4 | 21,9 | 4,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 161 | 72 | 82 | 10 |
Current financial liquidity indicator | 1.1772146224975586 | 1.9360084533691406 | 2.4832310676574707 | 0,6 |
Net dept to EBITDA | 0.3435145318508148 | -0.5014380216598511 | -0.9532361030578613 | -0,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane